<DOC>
	<DOCNO>NCT02672423</DOCNO>
	<brief_summary>The purpose study measure much abemaciclib get blood stream long take body get rid give capsule versus tablet ( ) . The effect high fat meal tablet formulation also evaluate . In addition , tolerability abemaciclib tablet capsule formulation evaluate . Information side effect may occur also collect . This study 3 part . Parts A C last 44 day include follow-up . Part B last 60 day include follow-up . Screening may occur 28 day first dose study drug . Participants allow enroll one part . This study research purpose intend treat medical condition .</brief_summary>
	<brief_title>A Study Abemaciclib Healthy Participants</brief_title>
	<detailed_description />
	<criteria>Healthy surgically sterile postmenopausal female sterile male Have body mass index ( BMI ) 18 32 kilogram per square meter ( kg/mÂ² ) Have know allergy abemaciclib , related compound , component formulation Regularly use know drug abuse and/or show positive finding urinary drug screen Show evidence human immunodeficiency virus ( HIV ) infection and/or positive human HIV antibody Show evidence hepatitis C and/or positive hepatitis C antibody Show evidence hepatitis B and/or positive hepatitis B surface antigen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>